Abstract
Although the classic childhood phenotypes of many developmental disorders have been established for some time, only in the past decade have the genetic etiologies of some of these disorders been identified. Investigations of the molecular basis of these conditions have resulted in the identification of new genes, leading to insights into the function of new proteins and biochemical pathways. In addition, genetic mechanisms previously unknown in humans, such as genomic imprinting, uniparental disomy, expansion of trinucleotide repeats, and facilitation of deletions and duplications by low-copy repeats, were recognized as the causes of some of these conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pieretti M, Zhang FP, Fu YH, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991;66:817–822.
Saul RA, Tarleton J, Fragile X syndrome. In: GeneReviews at GeneTests: Medical Genetics Information Resource [database online]. Seattle: University of Washington; 1997–2003.
Eichler EE, Richards S, Gibbs RA, et al. Fine structure of the human FMR1 gene. Hum Mol Genet. 1993;2:1147–1153.
Rousseau F, Heitz D, Biancalana V, et al. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med. 1991;325:1673–1681.
Fu YH, Kuhl DP, Pizzuti A, et al. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991;67:1047–1058.
Tassone F, hagerman RJ, Ikle DN, et al. FMRP expression as a potential prognostic indicator in fragile X syndrome. Am J Med Genet. 1999;84:250–261.
Engel E. A new genetic concept: uniparental disomy and its potential effect. Am J Med Genet. 1980;6:137–143.
Engel E, Antonarakis SE. Genomic Imprinting and Uniparental Disomy in Medicine: Clinical and Molecular Aspects. New York: Wiley-Liss; 2002.
Spence JE, Perciaccante RG, Greig GM, et al. Uniparental disomy as a mechanism for human genetic disease. Am J Hum Genet. 1988;42:217–226.
Sapienza C, Hall JG, Scriver CR, Beaudet AR, Sly WS, et al. Genome imprinting in human disease. In: Scriver CR, et al., eds. The Metabolic and Molecular Basis of Inherited Disease, 8th ed. New York: McGraw-Hill; 2001.
Gallagher RC, Pils, B, Albalwi M, et al. Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome. Am J Hum Genet. 2002;71:669–678.
Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet. 1997;15:70–73.
Cassidy SB, Schwartz S. Prader-Willi syndrome. In: GeneReviews at GeneTests: Medical Genetics Information Resource [database online]. Seattle: University of Washington; 1997–2003.
Williams CA, Lossie AC, Driscoll DJ. Angelman syndrome. In: GeneReviews at GeneTests: Medical Genetics Information Resource [database online]. Seattle: University of Washington; 1997–2003.
Malzac P, Webber H, Moncla A, et al. Mutation analysis of UBE3A in Angelman syndrome patients. Am J Hum Genet. 1998;62:1353–1360.
Beuten J, Sutcliff JS, Casey BM, et al. Detection of imprinting mutations in Angelman syndrome using a probe for exon α of SNRPN [letter]. Am J Med Genet. 1996;63:414–415.
Kubota T, Das S, Christian SL, et al. Methylation-specific PCR simplifies imprinting analysis [letter]. Nat Genet 1997;16:16–17.
American Society of Human Genetics/American College of Medical Genetics Test and Technology Transfer Committee. Diagnostic testing for Prader-Willi and Angelman syndromes: report of the ASHG/ACMG Test and Technology Transfer Committee. Am J Hum Genet. 1996;58:1085–1088.
Hagberg B, Aicardi J, Dias K, Ramos O. A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett’s syndrome: report of 35 cases. Ann Neurol. 1983;14:471–479.
Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet. 1999;23:185–188.
Shahbazian MD, Zoghbi HY. Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am J Hum Genet. 2002;71:1259–1272.
Fang P, Jin W, Glaze DG, Percy A, Zoghbi HY, Roa BB. MECP2 gene deletions account for ∼10% of Rett syndrome cases. The American Society of Human Genetics. 2004;476:2652.
Mnatzakanian GN, Lohi H, Munteanu I, et al. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet. 2004;36:339–341.
Buyse IM, Roa BB. Denaturing high-performance liquid chromatography and sequence analysis for MECP2 mutations in Rett syndrome. In: Potter NT, ed. Methods in Molecular Biology: Neurogenetics Methods and Protocols. Vol. 217. Totowa, NJ: Humana Press; 2002:119–130.
ACMG Laboratory Practice Committee Working Group. ACMG recommendations for standards for interpretation of sequence variations. Genet Med. 2000;2:302–330.
Morris CA. Williams Syndrome. In: Cassidy SB, Allanson JE, eds. Management of Genetic Syndromes, 2nd ed. New York: Wiley-Liss; 2005:655–665.
Osborne LR, Li M, Pober B, et al. A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet. 2001;29:321–325.
Li DY, Faury G, Taylor DG, et al. Novel arterial pathology in mice and humans hemizygous for elastin. J Clin Invest. 1998;102:1783–1787.
Tassabehji M, Metcalfe K, Karmiloff-Smith A, et al. Williams syndrome: use of chromosomal microdeletions as a tool to dissect cognitive and physical phenotypes. Am J Hum Genet. 1999;64:118–125.
Knight SJL, Flint J. Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis. J Med Genet. 2000;37:401–409.
Mefford HC, Trask BJ. The complex structure and dynamic evolution of human subtelomeres. Nat Rev Genet. 2002;3:91–102.
Biesecker LG. The end of the beginning of chromosome ends. Am J Med Genet. 2002;107:263–266.
Knight SJL, Lese CM, Precht KS, et al. An optimized set of human telomere clones for studying telomere integrity and architecture. Am J Hum Genet. 2000;67:320–332.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Carpenter, N.J., May, K., Roa, B., Tarleton, J. (2007). Developmental Disabilities. In: Leonard, D.G.B., Bagg, A., Caliendo, A.M., Kaul, K.L., Van Deerlin, V.M. (eds) Molecular Pathology in Clinical Practice. Springer, New York, NY. https://doi.org/10.1007/978-0-387-33227-7_6
Download citation
DOI: https://doi.org/10.1007/978-0-387-33227-7_6
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-33226-0
Online ISBN: 978-0-387-33227-7
eBook Packages: MedicineMedicine (R0)